Canton Biologics Completes Over 300 Million Yuan Series C Fi

Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital

On September 13th, Canton Biologics Co., Ltd. announced that it had recently completed a Series C financing round exceeding 300 million yuan. This round of financing was led by SDIC Venture Capital, with participation from Guangdong Technology

Related Keywords

Guangdong , Jilin , China , Itaipu , Anhui , Guangzhou , Xiao Shen , Canton Biologics , Canton Biologics Co Ltd , Guangdong Technology Financial Group , , Taipu Life Science Investment , Canton Biologic ,

© 2025 Vimarsana